L-PAMPO Trademark
L-PAMPO is a USPTO trademark filed by CHA Vaccine Research Institute Co., Ltd. Status: Registered.
Trademark Facts
| Mark | L-PAMPO |
|---|---|
| Serial Number | 79317594 |
| Registration Number | 6993672 |
| Status | Registered |
| Filing Date | 2021-06-23 |
| Registration Date | 2023-03-07 |
| Mark Type | Stylized |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | CHA Vaccine Research Institute Co., Ltd |
| Attorney of Record | Cynthia A. Moyer |
| Prosecution Events | 28 |
| Latest Event | FINO on 2023-07-03 |
Goods & Services
Vaccines for cattle; oral vaccine preparations; veterinary vaccines; viral vaccines; vaccines; adjuvants for use with vaccines; vaccine preparations; Veterinary substances and preparations for treating and preventing viruses and other infectious diseases, inflammatory diseases, genetic diseases, neurological diseases, autoimmune diseases, and cancer; human vaccine preparations; anti-microbial preparations for treating and preventing viruses and other infectious diseases; pharmaceutical preparations for treating and preventing viruses and other infectious diseases, inflammatory diseases, genetic diseases, neurological diseases, autoimmune diseases, and cancer; pharmaceutical compositions for the treatment and prevention of viruses and other infectious diseases, inflammatory diseases, genetic diseases, neurological diseases, autoimmune diseases, and cancer; reagents for medical use; diagnostic reagents for medical use for immunization diseases; diagnostic reagents for medical or veterinary purposes; clinical diagnostic reagents for medical use; preparations of microorganisms for medical or veterinary use; hepatitis vaccine; preparations for treatment of hepatitis; vaccines against flu; immunostimulants; immunomodulators; pharmaceutical preparations for the prevention of disorders of the immune system; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases; veterinary vaccines for bovine animals; veterinary vaccines for sheep; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for the treatment of cancer; drug delivery agents in the form of aqueous particles that provide a controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of injectable, inhalable, intranasal, oral, sublingual, transdermal, and topical compositions that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; anti-infectives; anti-viral agents; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of tumours; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; compounds for treating cancer; pharmaceutical preparations and substances for the prevention of cancer